All lobbying filings

W STRATEGIES, LLC

Lobbying for SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS · A clinical-stage biopharmaceutical company.

Filing 3rd Quarter - Report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 20, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Lobbying activity 1

Health Issues

Education and awareness of mental health issues especially as it relates to access for postpartum depression treatment and major depressive disorder.

Affiliated organizations 1

Section 6 of the LD-2: organizations that contribute to this lobbying or take an active part in directing it. On a trade association's filing, this is where its backers appear.

SUPERNUS PHARMACEUTICALS, INC.

Rockville, Maryland

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.